Change to the straight-line method of depreciation based on the actual operating conditions of production and research facilities
First written in FY2021-Q1. 1 of 2 entries say "Restated". Latest entry: FY2021-Q2.
No other company in this theme has enough history to compare yet.
- FY2021-Q2RestatedAnnual report
「As a result of this change, depreciation expense for the cumulative second quarter of the current consolidated fiscal year decreased by ¥67 million compared with the previous method, while operating profit, ordinary profit and quarterly profit before income taxes increased by ¥67 million each.」
The Company continued applying the straight-line method introduced in the first quarter. For the first half, depreciation expense decreased by ¥67 million, while operating profit, ordinary profit and quarterly profit before income taxes increased by ¥67 million each. - FY2021-Q1First statedAnnual report
「Previously, the Company used the declining-balance method to depreciate property, plant and equipment, excluding leased assets, except that the straight-line method was used for buildings acquired on or after 1 April 1998, excluding building fixtures, and for building fixtures and structures acquired on or after 1 April 2016. From the first quarter of the current consolidated fiscal year, the Company changed to the straight-line method. As a result of this change, depreciation expense for the cumulative first quarter of the current consolidated fiscal year decreased by ¥30 million compared with the previous method, while operating profit, ordinary profit and quarterly profit before income taxes increased by ¥30 million each.」
Based on changes in the utilisation of production and research facilities and in drug-discovery projects under the medium-term management plan "PEGASUS," the depreciation method for property, plant and equipment was changed from the declining-balance method to the straight-line method. Quarterly depreciation expense decreased by ¥30 million, while operating profit and other measures increased by ¥30 million each.